MétaCan
Menu
← Back to cohort
Record W4376876100 · doi:10.21203/rs.3.rs-2924093/v1

Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma

2023· preprint· en· W4376876100 on OpenAlexaff
Carolina Alves Costa Silva, Mélanie Bourgin, Gianmarco Piccinno, Gerty Schreibelt, Sylvère Durand, Marine Fidelle, Cissé Sow, Roxanne Birebent, Fanny Aprahamian, Paolo Manghi, Francesco Asnicar, Federica Pinto, Federica Armanini, Safae Terrisse, Bertrand Routy, Alexander Eggermont, Guido Kroemer, Nicola Segata, Lisa Derosa, Kalijn F. Bol, I. Jolanda M. de Vries, Laurence Zitvogel

Bibliographic record

VenueResearch Square · 2023
Typepreprint
Languageen
FieldImmunology and Microbiology
TopicImmunotherapy and Immune Responses
Canadian institutionsUniversité de Montréal
FundersRadboud Universitair Medisch CentrumRadboud Universiteit
KeywordsStage (stratigraphy)Randomized controlled trialMedicineMelanomaOutcome (game theory)Clinical trialOncologyInternal medicineBiologyCancer research

Abstract

fetched live from OpenAlex

Abstract Background: Melanoma is a malignancy where tumor immunosurveillance plays a major prognostic role, prompting the development of immunotherapy strategies, dominated earlier on by dendritic cell (DC)-based immunotherapy and recently, by immune checkpoint inhibitors (ICI). The taxonomic composition of the gut microbiome earned its credentials among predictors of survival in melanoma, by influencing the peripheral and tumoral immune tonus. Methods: In the MIND-DC phase III clinical trial (NCT02993315), 148 stage IIIB/IIIC cutaneous melanoma patients were randomized in a 2:1 ratio to adjuvant treatment with autologous conventional and plasmacytoid mature natural DC (nDC) versus placebo. Blood and stool samples were collected in 144 patients before and after 2 biweekly nDC injections to perform longitudinal metagenomics (MG) and metabolomics (MB), with the aim of finding predictors of 2-year recurrence-free survival (RFS). Results: Different microbial species were associated with prognosis of these patients with stage III melanoma, with the health-related Faecalibacterium prausnitzii standing out as the main beneficial taxon for no recurrence at 2 years (p=0.009). Therapy coincided with major perturbations of plasma acylcarnitines, as well as carboxylic and fatty acids (FA). Incidentally, despite randomization, patients in the nDC treatment arm exhibited a bias in their MG and MB baseline profiles, with a relative under-representation of F. prausnitzii, and perturbations of biliary salts and FA, compared to the control arm. Stool F. prausnitzii anticorrelated with plasma medium chain acylcarnitines and the combination of both of these MG and MB biomarkers markedly determined RFS. Conclusions: Altogether, the host-microbial interaction might be influenced by nDC-based immunotherapy in melanoma, a cancer highly dependent on lipid metabolism for its dissemination. We value the systematic MG profiling in randomized trials to avoid bias in baseline host-microbe metabolic and immune parameters.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.187
GPT teacher head0.487
Teacher spread0.300 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicImmunotherapy and Immune Responses→French-language works237,207→